Infant vitamin D supplementation and allergic conditions in adulthood: Northern Finland birth cohort 1966

Annals of the New York Academy of Sciences

Volumn 1037, Issue , 2004, Pages 84-95

  Hyppönen, Elina ^a   Sovio, Ulla ^b   Wjst, Matthias ^c   Patel, Swatee ^b,d   Pekkanen, Juha ^e   Hartikainen, Anna Liisa ^f   Järvelin, Marjo Riitta ^b,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF GREENWICH   (United Kingdom)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Allergic rhinitis; Allergy; Asthma; Atopy; Hygiene hypothesis; Infant supplementation; Vitamin D

Indexed keywords

CALCITRIOL; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; VITAMIN D;

ADULT; ADULTHOOD; ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPY; BIRTH ORDER; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FINLAND; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFANCY; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PREVALENCE; PRICK TEST; RICKETS; RISK FACTOR; SOCIAL CLASS; STATISTICAL ANALYSIS; TH2 CELL; VITAMIN SUPPLEMENTATION;

EID: 14544307497     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1337.013     Document Type: Conference Paper

References (27)

1. MATHEU, V. et al. 2003. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112: 585-592.
2. OVERBERGH, L. et al. 2000. 1 alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65. Diabetes 49: 1301-1307.
3. IHO, S. et al. 1985. The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3. Immunol. Lett. 11: 331-336.
4. REICHEL, H. et al. 1987. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 84: 3385-3389.
5. LEMIRE, J.M. et al. 1995. Immunosuppressive actions of 1,25-dihydroxy vitamin D3: preferential inhibition of Th1 functions. J. Nutr. 125: 1704S-1708S.
6. JIRAPONGSANANURUK, O. et al. 2000. Additive immunosuppressive effects of 1,25-dihydroxy vitamin D3 and corticosteroids on TH1, but not TH2, responses. J. Allergy Clin. Immunol. 106: 981-985.
7. BOONSTRA, A. et al. 2001. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980.
8. CANTORNA, M.T. et al. 1998. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J. Immunol. 160: 5314-5319.
9. THE EURODIAB SUBSTUDY 2 STUDY GROUP. 1999. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 51-54.
10. GIULIETTI, A. et al. 2004. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 47: 451-432.
11. HYPPÖNEN, E. et al. 2001. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500-1503.
12. GALE, E.A. 2002. A missing link in the hygiene hypothesis? Diabetologia 45: 588-594.
13. ZELLA, J.B. & H.F. DELUCA. 2003. Vitamin D and autoimmune diabetes. J. Cell Biochem. 88: 216-222.
14. HOLT, P.G. 2004. The role of genetic and environmental factors in the development of T-cell mediated allergic disease in early life. Paediatr.Respir. Rev. 5: S27-S30.
15. WARNER, J.O. 2004. The early life origins of asthma and related allergic disorders. Arch. Dis. Child 89: 97-102.
16. SALAM, M.T. et al. 2004. Early-life environmental risk factors for asthma: findings from the children's health study. Environ. Health Perspect. 112: 760-765.
17. BACH, J.F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.
18. BRUSTAD, M. et al. 2004. Predictors for cod-liver oil supplement use - the Norwegian Women and Cancer Study. Eur. J. Clin. Nutr. 58: 128-136.
19. WJST, M. & S. DOLD. 1999. Genes, factor X, and allergens: what causes allergic diseases? Allergy 54: 757-759.
20. RANTAKALLIO, P. 1969. Groups at risk in low birth weight infants and perinatal mortality. Acta Padiatr. Scand. (Suppl.) 193: 1-71.
21. RANTAKALLIO, P. & H. MÄKINEN. 1983. The effect of maternal smoking on the timing of deciduous tooth eruption. Growth 47: 122-128.
22. XU, B. et al. 2001. Caesarean section and risk of asthma and allergy in adulthood. J. Allergy Clin. Immunol. 107: 732-733.
23. STATA CORPORATION. 2003. Intercooled Stata, version 8. College Station, TX, USA.
24. LEPPO, K. & K. HASUNEN. 2003. Recommendation for vitamin D supplementation (D-vitamiinivalmisteiden käyttösuositus, in Finnish). Ministry of Social Welfare and Health.Recommendations. http://stm.teamware.com/ Resource.phx/ajank/suost/dvita-miini.htx. Last accessed 11.05.2004.
25. GARTNER, L.M. & F.R. GREER. 2003. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics 111: 908-910.
26. VIETH, R. 2004. Misuse of terminology to imply that 1,25-dihydroxy- vitamin D is a nutrient: there is no evidence for an association between vitamin D and allergy. J. Allergy Clin. Immunol. 113: 790-791.
27. HALLMAN, N. et al. 1964. Riisitaudin ennakkotorjunnasta. [Prevention of rickets, in Finnish]. Duodecim 80: 185-189.